Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	18.73	25.08	21.12
Graham Fair Price	98.02	12318.85	6220.95
PEG	-92.30	0.02	-0.24
Price/Book	1.22	0.49	0.49
Price/Cash Flow	83.45	-16.27	8.87
Prices/Earnings	-72.76	5.27	19.36
Price/Sales	3.98	1.27	1.22
Price/FCF	83.45	-16.27	8.87
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-19.98	0.25	0.31
Operating Margin	-35.05	0.06	0.09
ROA	272.75	< 0.005	< 0.005
ROE	< 0.005	0.02	271.62
ROIC	< 0.005	< 0.005	78.78
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.06	-88.27
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.08	-0.35	-330.52
EPS QOQ	-0.80	2.82	253.59
FCF QOQ	0.25	-1.57	530.25
Revenue QOQ	-0.02	< 0.005	99.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	123.13	113.24	-8.03
Days Sales Outstanding (DSO)	74.26	82.88	11.60
Inventory Turnover	0.73	0.79	8.73
Debt/Capitalization	0.51	0.50	-1.02
Quick Ratio	0.66	0.66	0.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16524.17	16973.98	2.72
Cash	3082.74	2690.81	-12.71
Capex	-935.25	-676.54	27.66
Free Cash Flow	908.75	-515.04	-43.32
Revenue	6605.42	6604.93	< 0.005
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.17	1.18	0.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.72	16.30	18.86
Naive Interpretation	Member

06 - Financial Health · Bad

Rating